A Study of GSK573719 in Healthy Japanese Male Subjects
Status:
Completed
Trial end date:
2009-12-18
Target enrollment:
Participant gender:
Summary
This is a single centre, randomized, double blind, placebo controlled, single and repeat dose
study to investigate the safety, tolerability, and pharmacokinetics of inhaled dose of
GSK573719 with lactose and containing magnesium stearate by a novel dry powder device in
healthy Japanese male subjects.